Logo del repository
  1. Home
 
Opzioni

Hydronephrosis as a Late Complication of ProACT Implantation

Morreale, Carmelo
•
Gregori, Andrea
•
Ranzoni, Stefania
altro
Liguori, Giovanni
2024
  • journal article

Periodico
UROLOGY
Abstract
A n 83-year-old male was referred to the urology clinic because of acute kidney failure and perineal pain and urinary urgency. The patient was treated in 2009 with implantation of an adjustable continence therapy device (ProACT, Uromedica), because of stress urinary incontinence (SUI) after radical prostatectomy (RP). The procedure was performed with transrectal ultrasound (TRUS) guidance under local anesthesia. At the admission, the patient reported perineal and left flank pain. Serum creatinine level was 1.45 mg/dL. All other blood and urine test results were within range. Computed Tomography (CT) imaging revealed left hydronephrosis due to compression of the distal tract of the left ureter by the left side balloon of the device that migrated in the retropubic space, 3 cm above the original position. What would you do next? (A) Perform a left nephrostomy; (B) Positioning a left ureteral stent; (C) Deflate, remove, and eventually reimplant the device; (D) Deflate the balloon without removing the device. What to do next? (C) Deflate, remove, and eventually reimplant the device. Implanting a ProACT is a safe and efficacious treatment for SUI after RP. The adjustable continencetherapy has high rate of migration as long-term complication.4 The first line treatment after the dislocation of the device causing complications (hydronephrosis, erosion, infections) is the explantation since the procedure is brief and minimally invasive. The patient underwent explantation of the device, performed with TRUS guidance under local anesthesia through two small perineal incisions. Two days later the patient was dismissed after the normalization of the serum creatinine level (0.79 mg/dL) and resolution of hydronephrosis and pain. No complication occurred, except for the recurrence of urinary incontinence (use of 3 pads/die). Patients can be reimplanted or treated with a more invasive treatment option. In our case, the patient decided not to be reimplanted with a new device. Serum creatinine level at 3, 6, and 12 months after the procedure was in range and the abdominal ultrasound tests showed no recurrence of hydronephrosis.
DOI
10.1016/j.urology.2024.03.020
WOS
WOS:001295240300001
Archivio
https://hdl.handle.net/11368/3081441
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85190294541
https://www.sciencedirect.com/science/article/pii/S0090429524001687?via=ihub
Diritti
open access
license:copyright editore
license:creative commons
license uri:iris.pri02
license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/
FVG url
https://arts.units.it/request-item?handle=11368/3081441
Soggetti
  • Hydronephrosi

  • ProACT Implantation

  • Late Complication

google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback